Eli Lilly and Company

Eli Lilly and Company's reported carbon emissions

Eli Lilly and Company, headquartered in GB, reported its carbon emissions for several years, with the most recent data available for 2024. In 2024, Eli Lilly and Company reported Scope 1 emissions of approximately 192,000,000 kg CO2e and Scope 2 emissions of approximately 258,000,000 kg CO2e (market-based). For 2023, the company's Scope 1 emissions were approximately 182,000,000 kg CO2e, and Scope 2 emissions were approximately 345,000,000 kg CO2e (market-based). Scope 3 emissions for 2023 totalled approximately 5,139,500,000 kg CO2e, with significant contributions from purchased goods and services (approximately 3,098,800,000 kg CO2e) and upstream transportation and distribution (approximately 957,400,000 kg CO2e). Eli Lilly and Company has set ambitious climate commitments. The company aims to be carbon neutral in its own operations (Scope 1 and 2 emissions) by 2030. Between 2020 and 2023, the company achieved a significant absolute emissions reduction of 26% in its own operations. They also reported a 3% year-on-year reduction from 2022 in their operations for the same period. Previously, between 2020 and 2022, they achieved more than a 20% reduction in operational greenhouse gas emissions. The company's reporting indicates a focus on enhancing its full value-chain emissions reporting. Eli Lilly and Company's emissions data is not cascaded from a parent organisation, indicating it reports its own environmental performance.